Methenolone Propionate

Primabol is an injectable version of the steroid methenolone enanthate. An enanthate ester is used to slow the steroid’s release from a site of injection. Methenolone enanthate offers a similar pattern of steroid release as testosterone enanthate, with blood hormone levels remaining markedly elevated for approximately 2 weeks. Methenolone itself is a moderately strong anabolic steroid with very low androgenic properties. Its anabolic effect is considered to be slightly less than nandrolone decanoate on a milligram for milligram basis. Methenolone enanthate is most commonly used during cutting cycles, when lean mass gain, not a raw mass increase, is the main objective. The combination of strong anabolic, weak androgenic, and non-estrogenic nature of this drug makes the methenolone enanthate a very desirable for building lean muscularity without side effects.

Side effects
Methenolone is widely considered very ‘mild’ in the sense that it presents absolutely zero risk of any Estrogenic side effects at any dose. Both methenolone and it`s close brother, oxandrolone are anabolic steroids that have been utilized medically in the treatment of women and children with very little risk of ill effects. Although Methenolone possesses a very low androgenic strength rating in comparison to Testosterone, Methenolone might still exhibit androgenic side effects especially in individuals with a greater sensitivity to this category of side effects. Androgenic side effects include the following: increased sebum secretion (oily skin), increased bouts of acne (linked to increased sebum secretion), bodily and facial hair growth, and the increased risk of triggering Male Pattern Baldness.

​

Administration
The usual administration among male athletes is a 200-300 mg per week dosage, which is taken for 6 to 12 weeks. Such amount is sufficient to promote very noticeable increases in lean muscle tissue. It is, however, not unusual to see the drug taken in doses as high as 600 mg per week or more, although such amounts are likely to highlight a more androgenic side of methenolone, as well as exacerbate its negative effects on serum lipids.